Precision Biosensor Inc is a Korea-based company primarily engaged in the development, manufacture and sale of in vitro diagnostic devices and reagents. The Company manufactures and sells clinical chemical diagnostic products such as human and veterinary testers and cartridges. The Company also manufactures and sells immunodiagnostic products such as time-resolved fluorescence products and gold products. The company sells its products in domestic and overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-10-16	₩1,490.00	+8.44%	4,131
26-10-15	₩1,374.00	-5.89%	4,126
26-10-14	₩1,460.00	-0.61%	2,587
26-10-13	₩1,469.00	-2.33%	34,084
26-10-12	₩1,504.00	+1.08%	4,183

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-10-16			5-day change	1st Jan Change
1,490.00 ^KRW	+8.44%		+0.13%	-43.88%

01-31	Precision Biosensor, Inc. completed the acquisition of CT BIO Co., Ltd.	CI
11-13	Precision Biosensor, Inc. agreed to acquire CT BIO Co., Ltd. for KRW 11.1 billion.	CI

Market Cap	32.7B 24.53M 21.81M 20.18M 18.41M 34.67M 2.33B 35.29M 243M 95.3M 1.21B 92M 90.04M 3.88B	P/E 2024	-4.49x	P/E 2025	-3.34x
Enterprise Value	36.9B 27.68M 24.61M 22.77M 20.78M 39.12M 2.63B 39.82M 274M 108M 1.37B 104M 102M 4.38B	EV / Sales 2024	2.44x	EV / Sales 2025	2.6x
Free-Float	40.1%	Yield 2024 *	-	Yield 2025	-

01-31	Precision Biosensor, Inc. completed the acquisition of CT BIO Co., Ltd.	CI
11-13	Precision Biosensor, Inc. agreed to acquire CT BIO Co., Ltd. for KRW 11.1 billion.	CI
11-03	Precision Biosensor, Inc. announced that it has received KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
25-10-16	Precision Biosensor, Inc. announced that it expects to receive KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
24-10-01	Kwang Dong Pharmaceutical Co., Ltd. completed the acquisition of 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo.	CI
24-07-01	Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion.	CI
24-03-25	Qlife Signs Letter of Intent with Precision Biosensor	CI
24-02-07	Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	CI
24-02-05	Precision Biosensor, Inc. announced that it expects to receive KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and another investor	CI
22-09-19	Precision Biosensor, Inc.(KOSDAQ:A335810) dropped from S&P Global BMI Index	CI
21-11-17	Precision Biosensor, Inc. announced that it has received KRW 150 billion in funding	CI
21-11-15	Precision Biosensor, Inc. announced that it expects to receive KRW 150 billion in funding	CI
21-06-21	Precision Biosensor, Inc.(KOSDAQ:A335810) added to S&P Global BMI Index	CI

24-05-28	QLIFE HOLDING AB, Interim Report Q1, January to March 2024	AQ
24-03-25	Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	AQ

Precision Biosensor, Inc. Stock

Stocks

A335810

KR7335810008

Medical Equipment, Supplies & Distribution

Valuation: Precision Biosensor, Inc.

Chart: Precision Biosensor, Inc.

Latest news: Precision Biosensor, Inc.

Press Releases: Precision Biosensor, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Precision Biosensor, Inc.

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 day	+8.44%
1 week	+0.13%
1 month	-1.19%
3 months	+0.40%
6 months	-33.78%
Current year	-43.88%

1 week	1,361	1,533
1 month	1,361	1,798
Current year	1,106	3,345
1 year	1,106	3,505
3 years	1,106	6,350
5 years	1,106	14,000
10 years	1,106	41,000

Manager	Title	Age	Since
Han-Sin Kim CEO	Chief Executive Officer	58	2018-04-30
Jun-Hong Min CTO	Chief Tech/Sci/R&D Officer	56	-
Moon-Seon Hwang CTO	Chief Tech/Sci/R&D Officer	55	2022-08-31

Director	Title	Age	Since
Han-Sin Kim BRD	Director/Board Member	58	2018-04-30
Sung-Won Choi BRD	Director/Board Member	56	-
Hyuk-Jong Lee BRD	Director/Board Member	56	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRECISION BIOSENSOR, INC.	+8.44%	+0.13%	-50.33%	-74.75%	22.44M
ABBOTT LABORATORIES	+0.20%	+6.50%	-18.97%	+15.43%	181B
MEDTRONIC PLC	-0.73%	+7.98%	-0.62%	+31.67%	117B
STRYKER CORPORATION	+0.49%	+6.39%	-20.31%	+14.26%	112B
ESSILORLUXOTTICA	+3.83%	+7.97%	-42.86%	-5.91%	76.56B
CENCORA, INC.	-0.14%	+6.09%	+6.67%	+80.40%	65.15B
HOYA CORPORATION	+2.79%	+2.50%	+19.39%	+64.11%	52.79B
BECTON, DICKINSON AND COMPANY	-1.04%	+4.92%	+2.67%	-25.88%	52.78B
IDEXX LABORATORIES, INC.	+2.41%	+9.20%	-12.33%	+31.48%	43.11B
MEDLINE INC.	-1.67%	+0.62%	-	-	32.08B
Average	+1.40%	+4.46%	-12.97%	+14.54%	73.3B
Weighted average by Cap.	+0.44%	+5.70%	-11.43%	+23.20%

	2024	2025
Net sales	19.13B 14.35M 12.76M 11.81M 10.77M 20.28M 1.36B 20.65M 142M 55.76M 710M 53.82M 52.68M 2.27B	19.93B 14.94M 13.29M 12.29M 11.22M 21.12M 1.42B 21.5M 148M 58.06M 739M 56.05M 54.86M 2.37B
Net income	-7.31B -5.48M -4.87M -4.51M -4.11M -7.74M -520M -7.88M -54.28M -21.29M -271M -20.55M -20.11M -867M	-10.02B -7.52M -6.69M -6.18M -5.64M -10.62M -713M -10.81M -74.48M -29.21M -372M -28.19M -27.59M -1.19B
Net Debt	13.84B 10.38M 9.23M 8.54M 7.79M 14.68M 985M 14.94M 103M 40.34M 514M 38.95M 38.11M 1.64B	4.2B 3.15M 2.8M 2.59M 2.36M 4.45M 299M 4.53M 31.19M 12.23M 156M 11.81M 11.56M 498M